[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.200.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

July 2019 - January 1920

Decade

Year

Issue

February 2016, Vol 152, No. 2, Pages 125-230

In This Issue of JAMA Dermatology

Highlights

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):125. doi:10.1001/jamadermatol.2015.3233
Viewpoint

Innovative New Drugs for Serious Nonlethal Diseases: The Cost to Develop and the Cost to Buy

Abstract Full Text
JAMA Dermatol. 2016;152(2):139-140. doi:10.1001/jamadermatol.2015.4903

This Viewpoint highlights that studies using unvalidated surrogate end points has led to the availability of many new anticancer drugs and that adopting similar standards for drugs aimed at nonlethal diseases might produce more drugs for these conditions.

The Need for Greater Regulation, Guidelines, and a Consensus Statement for Tattoo Aftercare

Abstract Full Text
JAMA Dermatol. 2016;152(2):141-142. doi:10.1001/jamadermatol.2015.4000

This Viewpoint on tattoo aftercare recommends the creation of evidence-based best practices that state public health departments and tattooists can use to improve care.

Editorial

Online Reviews of Physicians: Valuable Feedback, Valuable Advertising

Abstract Full Text
JAMA Dermatol. 2016;152(2):143-144. doi:10.1001/jamadermatol.2015.3951
Original Investigation

Evaluation of Dermatology Practice Online Reviews: Lessons From Qualitative Analysis

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):153-157. doi:10.1001/jamadermatol.2015.3950

This study identifies the type of information included on websites that provide consumer reviews of physicians and aspects of their practice settings.

Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):158-163. doi:10.1001/jamadermatol.2015.3897

This survey study reports that the price of 19 commonly prescribed dermatologic drugs increased by a mean of 401% between 2009 and 2015, with the majority of the increase occurring after 2011.

Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):164-172. doi:10.1001/jamadermatol.2015.3029

This retrospective study of individuals with rheumatoid arthritis and inflammatory bowel disease reports that methotrexate use is associated with an increased risk of a second nonmelanoma skin cancer.

Correlation of Inflammation in Frozen Sections With Site of Nonmelanoma Skin Cancer

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):173-176. doi:10.1001/jamadermatol.2015.3649

In this study of frozen sections of nonmelanoma skin cancer, histologic inflammation was associated with modestly adjacent tumor and the absence of inflammation was associated with the absence of additional tumor.

Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):177-183. doi:10.1001/jamadermatol.2015.3902

This population-based cohort study found that recipients of allogeneic hematopoietic stem-cell transplants had an increased risk of skin cancer compared with renal transplant recipients and nontransplant individuals.

Influence of Quality of Relationship Between Patient With Melanoma and Partner on Partner-Assisted Skin Examination Education: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):184-190. doi:10.1001/jamadermatol.2015.2819

This randomized clinical trial reports on the factors that led to the greatest benefit in the training of patients with melanoma and their partners in early-detection skin self-examination.

Antibiotic Exposure, Infection, and the Development of Pediatric Psoriasis: A Nested Case-Control Study

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):191-199. doi:10.1001/jamadermatol.2015.3650

This nested case-control study of children with newly diagnosed psoriasis reports that infections are associated with the development of pediatric psoriasis, although antibiotics do not contribute substantially to that risk.

Case Report/Case Series

A Digital Dermoscopy Follow-up Illustration and a Histopathologic Correlation for Angulated Lines in Extrafacial Lentigo Maligna

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):200-203. doi:10.1001/jamadermatol.2015.4132

This case report describes 4 cases of extrafacial lentiginous lesions in 3 patients in whom straight angulated lines were observed as the only key for diagnosis.

JAMA Dermatology Clinicopathological Challenge

Painful and Pruritic Papules in the Gray Shading of a Tattoo

Abstract Full Text
JAMA Dermatol. 2016;152(2):205-206. doi:10.1001/jamadermatol.2015.3448

A woman presented with multiple painful, pruritic papules and pustules that developed 1 week after the addition of gray shading toa tattoo; results from a routine wound culture were negative for organisms. What is your diagnosis?

Bruising and Hemorrhagic Vesicles on the Tongue

Abstract Full Text
JAMA Dermatol. 2016;152(2):207-208. doi:10.1001/jamadermatol.2015.4065

A woman in her 70s with recently diagnosed diastolic heart failure was admitted for worsening dyspnea and also reported easy bruising with minor trauma and erosions on the lateral tongue. What is your diagnosis?

Linear Scars in a 4-Week-Old Girl

Abstract Full Text
JAMA Dermatol. 2016;152(2):209-210. doi:10.1001/jamadermatol.2015.4191

A 4-week-old girl who had erosions on the left leg, left side of the neck, abdomen, and left ear at birth presented with linear scars. Clinical examination revealed erythematous atrophic streaks along Blaschko lines and soft skin-colored papules on the left leg. What is your diagnosis?

Research Letter

Receptivity to Internet-Delivered Interventions to Promote Skin Self-examination and Sun Protection Behaviors in Patients With Melanoma

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):213-215. doi:10.1001/jamadermatol.2015.2978

This survey of adults with a diagnosis of melanoma assessed patient characteristics associated with a willingness to receive Internet-delivered interventions to promote skin self-examination and sun protection behaviors.

Seasonal and Geographic Patterns in Tanning Using Real-Time Data From Google Trends

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):215-217. doi:10.1001/jamadermatol.2015.3008

This study examines Internet search data for seasonal interest in tanning practices to enable the design of timely harm reduction interventions.

Nevus Anemicus and Bier Spots in Tuberous Sclerosis Complex

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):217-218. doi:10.1001/jamadermatol.2015.3999

This study describes vascular lesions in patients with tuberous sclerosis complex, which could be minor cutaneous markers of the disease.

Analysis of Online Ratings of Dermatologists

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):218-219. doi:10.1001/jamadermatol.2015.4991

This study analyzes mean ratings of a representative sample of dermatologists on 5 popular online physician rating sites.

Use of Health Care Resources and Costs After Patient Nonattendance in Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):220-221. doi:10.1001/jamadermatol.2015.4030

This review of medical records assesses the use of health care resources and costs associated with dermatology nonattendance in patients at university-affiliated dermatology clinics.

Observation

Cutaneous Vasculopathy as an Adverse Effect of the Anti–Vascular Endothelial Growth Factor Agent Axitinib

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):222-223. doi:10.1001/jamadermatol.2015.3209

This case report describes the occurrence of cutaneous vasculopathy as an adverse effect of treatment with the anti–vascular endothelial growth factor agent axitinib.

Intermittent Vismodegib Therapy in Basal Cell Nevus Syndrome

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):223-224. doi:10.1001/jamadermatol.2015.3210

This report of 2 cases suggests that use of an intermittent dosing regimen for vismodegib therapy might be an effective means to treat basal cell nevus syndrome and minimize adverse effects.

Bullous Pemphigoid Associated With Linagliptin Treatment

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):224-226. doi:10.1001/jamadermatol.2015.2939

This report of cases describes 2 patients with bullous pemphigoid associated with linagliptin treatment for diabetes.

Primary Melanoma of the Penis in 3 Patients With Lichen Sclerosus

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):226-227. doi:10.1001/jamadermatol.2015.3404

This report of cases describes primary melanoma of the penis in 3 patients with genital lichen sclerosus.

Sorafenib-Induced Eruption Mimicking Erythema Multiforme

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):227-228. doi:10.1001/jamadermatol.2015.2930

This case report describes a sorafenib-induced eruption mimicking erythema multiforme in an older man.

BRAF Inhibition in a Lung Transplant Recipient With Metastatic Melanoma

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):228-230. doi:10.1001/jamadermatol.2015.2910

This case report illustrates BRAF inhibition in a lung transplant recipient with metastatic melanoma.

Notable Notes

Discrimination Against People With Dermatologic Diseases

Abstract Full Text
JAMA Dermatol. 2016;152(2):140. doi:10.1001/jamadermatol.2015.3886

Biopsy—What’s in the Name?

Abstract Full Text
JAMA Dermatol. 2016;152(2):190. doi:10.1001/jamadermatol.2015.3677

The Evolution of Laser Technology in Dermatology

Abstract Full Text
JAMA Dermatol. 2016;152(2):199. doi:10.1001/jamadermatol.2015.4133

Crazy in Love

Abstract Full Text
JAMA Dermatol. 2016;152(2):230. doi:10.1001/jamadermatol.2015.1521
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2016;152(2):129. doi:10.1001/jamadermatol.2015.3234
×